Clinical Trials Logo

Clinical Trial Summary

We hypothesise that atorvastatin changes immune activation among HAART-treated adults with suboptimal cluster cell differentiation 4 (CD4) recovery by 25%


Clinical Trial Description

The investigators have previously shown that up to 40% of HAART-treated adults have suboptimal CD4 recovery despite viral suppression. The investigators have also shown that immune activation and exhaustion are significantly higher among patients that do not exhibit satisfactory rise in CD4 counts despite viral suppression (suboptimal responders); when compared with their counterparts with viral suppression and satifactory CD4 count recovery (optimal responders). Given that atorvastatin changes immune activation in this pilot study, then larger studies can be done to understand its effect on CD4 count increase among suboptimal responders. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01766076
Study type Interventional
Source Makerere University
Contact
Status Completed
Phase Phase 3
Start date January 2013
Completion date March 2014

See also
  Status Clinical Trial Phase
Recruiting NCT02266992 - Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study Phase 2
Recruiting NCT00974454 - Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART) N/A
Recruiting NCT00974519 - The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients N/A
Recruiting NCT00974285 - Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients N/A
Active, not recruiting NCT02337322 - Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir Phase 4
Recruiting NCT02542020 - Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis
Completed NCT01976715 - Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
Completed NCT01840722 - Brief Intervention for Rural Women at High Risk for HIV/HCV N/A